AstraZeneca (AZN)
NASDAQ: AZN
· Real-Time Price · USD
79.22
0.75 (0.96%)
At close: Aug 15, 2025, 3:58 PM
78.60
0.14%
Pre-market: Aug 15, 2025, 09:28 AM EDT
AstraZeneca Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 30, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 7.06B | 5.23B | 5.49B | 4.8B | 6.92B | 7.84B | 5.84B | 4.87B | 5.66B | 6.23B | 6.17B | 4.46B | 4.82B | 5.76B | 6.33B | 7.07B | 15.57B | 7.64B |
Short-Term Investments | 50M | 165M | 166M | 133M | 160M | 180M | 20M | 244M | 148M | 230M | 239M | 440M | 70M | 61M | 69M | 82M | 62M | 129M |
Long-Term Investments | n/a | 1.9B | 1.73B | 2.01B | 1.87B | 1.51B | 1.66B | 1.05B | 995M | 1B | 903M | 662M | 1.11B | 1.18B | 1.17B | 1.5B | 1.06B | 931M |
Other Long-Term Assets | 4.85B | 1.14B | 1.28B | 1.37B | 5.76B | 1.14B | 1.05B | 1.16B | 1.06B | 1.03B | 1.15B | 1.34B | 1.06B | 1.01B | 1.07B | 983M | 751M | 793M |
Receivables | 14.17B | 13.25B | 12.97B | 11.88B | 11.05B | 11.07B | 8.41B | 11.3B | 11.09B | 10.29B | 7.21B | 9.34B | 8.91B | 8.68B | 6.03B | 8.26B | 6.36B | 6.28B |
Inventory | 6.47B | 5.88B | 5.29B | 5.66B | 5.67B | 5.34B | 5.42B | 5.29B | 5.05B | 4.97B | 4.7B | 5.08B | 6.22B | 7.62B | 8.98B | 10.53B | 4.76B | 4.28B |
Other Current Assets | 1.2B | 1.61B | 1.91B | 1.68B | 1.6B | 1.16B | 3.75B | 794M | 884M | 548M | 3.11B | 1.29B | 902M | 517M | 3.32B | 756M | 527M | 411M |
Total Current Assets | 28.94B | 26.14B | 25.83B | 24.16B | 25.39B | 25.59B | 25.05B | 22.5B | 22.84B | 22.27B | 22.59B | 20.22B | 20.92B | 22.65B | 26.24B | 26.69B | 27.27B | 18.73B |
Property-Plant & Equipment | 13.23B | 12.3B | 11.65B | 11.51B | 10.83B | 10.62B | 10.5B | 9.7B | 9.62B | 9.6B | 9.45B | 9.23B | 9.63B | 10.02B | 10.17B | 10.16B | 9.03B | 8.85B |
Goodwill & Intangibles | 59.15B | 58.68B | 58.2B | 60.53B | 60.49B | 58.81B | 58.14B | 57.63B | 58.29B | 59.29B | 59.13B | 59.29B | 59.72B | 61.23B | 62.38B | 64.19B | 31.8B | 32.11B |
Total Long-Term Assets | 83.48B | 80.11B | 78.21B | 80.77B | 78.95B | 76.7B | 76.06B | 73.58B | 73.7B | 74.42B | 73.89B | 73.96B | 75.66B | 77.63B | 79.12B | 80.53B | 46.37B | 46.19B |
Total Assets | 112.42B | 106.25B | 104.03B | 104.92B | 104.34B | 102.29B | 101.12B | 96.09B | 96.54B | 96.69B | 96.48B | 94.19B | 96.58B | 100.27B | 105.36B | 107.22B | 73.64B | 64.93B |
Account Payables | 23.99B | 22.54B | 22.46B | 21.68B | 20.46B | 19.7B | 3.27B | 19.72B | 18.93B | 18.42B | 2.55B | 16.84B | 16.98B | 17.04B | 2.82B | 17.76B | 16.84B | 16.5B |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 987M | 780M | 994M |
Short-Term Debt | 6.49B | 3.42B | 2.16B | 1.25B | 5.12B | 6.14B | 6.12B | 6.27B | 5.44B | 4.46B | 6.27B | 6.33B | 3.09B | 2.93B | 2.66B | 3.7B | 3.6B | 2.93B |
Other Current Liabilities | 1.27B | 2.81B | 1.5B | 1.2B | 2.69B | 2.78B | 5.14B | 2.36B | 1.77B | 1.75B | 3.81B | 1.47B | 1.52B | 2.55B | 4.52B | 1.96B | 1.58B | 1.87B |
Total Current Liabilities | 33.54B | 29.13B | 27.87B | 25.93B | 28.57B | 28.9B | 30.54B | 28.59B | 26.38B | 24.86B | 26.29B | 24.85B | 21.82B | 22.74B | 22.59B | 23.65B | 22.22B | 21.51B |
Long-Term Debt | 24.71B | 26.74B | 26.51B | 28.89B | 27.29B | 27.31B | 22.4B | 22.3B | 24.4B | 27.05B | 23.91B | 24.07B | 27.39B | 28.87B | 29.72B | 29.72B | 25.6B | 18.87B |
Other Long-Term Liabilities | 4.47B | 8.06B | 4.37B | 4.63B | 7.94B | 7.62B | 8.15B | 7.23B | 7.63B | 8.24B | 8.5B | 9.44B | 10.73B | 11.58B | 13.01B | 13.2B | 9.64B | 9.63B |
Total Long-Term Liabilities | 34.08B | 35.99B | 35.3B | 38.19B | 36.18B | 35.89B | 31.41B | 30.28B | 32.75B | 36.02B | 33.13B | 34.18B | 38.81B | 41.17B | 43.48B | 43.66B | 35.73B | 28.97B |
Total Liabilities | 67.61B | 65.12B | 63.16B | 64.12B | 64.74B | 64.79B | 61.95B | 58.87B | 59.13B | 60.88B | 59.42B | 59.03B | 60.63B | 63.91B | 66.08B | 67.31B | 57.95B | 50.48B |
Total Debt | 32.84B | 31.72B | 30.11B | 31.56B | 33.53B | 34.55B | 28.62B | 28.58B | 29.84B | 31.5B | 29.23B | 29.3B | 29.53B | 31.1B | 30.78B | 31.91B | 27.5B | 20.13B |
Common Stock | 388M | 388M | 388M | 388M | 388M | 388M | 388M | 387M | 387M | 387M | 387M | 387M | 387M | 387M | 387M | 387M | 328M | 328M |
Retained Earnings | 7.02B | 3.36B | 3.16B | 3.14B | 1.85B | -212M | 1.5B | -434M | -234M | -1.82B | -574M | -2.47B | -1.66B | -1.23B | 1.71B | 2.2B | 5.33B | 4.09B |
Comprehensive Income | n/a | 2.05B | n/a | 1.99B | 2.08B | 2.08B | -949M | 2.08B | 2.08B | 2.07B | -1.63B | 2.08B | 2.07B | 2.05B | 111M | 2.04B | 2.03B | 2.04B |
Shareholders Equity | 44.72B | 41.04B | 40.79B | 40.72B | 39.51B | 37.45B | 39.14B | 37.2B | 37.39B | 35.79B | 37.04B | 35.13B | 35.93B | 36.34B | 39.27B | 39.74B | 15.68B | 14.43B |
Total Investments | 2.14B | 2.06B | 1.9B | 2.15B | 1.87B | 1.7B | 1.68B | 1.29B | 1.14B | 1.23B | 1.14B | 1.1B | 1.18B | 1.24B | 1.24B | 1.58B | 1.12B | 1.06B |